The National Institute of Allergies and Infectious Diseases is leading COVID-19 clinical trial efforts through a large-scale network, called the COVID-19 Prevention Network (CoVPN). Dr. Jim Kublin, the executive director of operations program for CoVPN, shares more about this government-funded clinical trials network for COVID-19, the importance of diversity in research, and how tech is rapidly advancing medical discoveries.
HealthCast
Season 2
Episode 1
23m listen
Ensuring Participant Diversity in COVID-19 Vaccine Trials
Modern technology has the power to overcome clinical trial participation challenges.
-
Dr. Jim Kublin Executive Director of Operation Programs CoVPN
Related Content
-
OPM Navigates AI Governance Through People
OPM's Taka Ariga explores AI's role in an efficient federal workforce and operations, focusing on trust, data integrity and storytelling.
19m listen -
HHS CIO Eyes Special Cyber Measures to Secure Data
Data security and customer experience are top priorities for Jennifer Wendel, the newly confirmed permanent CIO at the Department of Health and Human Services (HHS).
25m listen -
Coming Soon: AI GovCast Season 2 Explores Federal Artificial Intelligence
The first season of AI GovCast brought listeners the voices at the forefront of government's AI revolution. Coming Jan. 14, season two will dive deeper into AI governance, use cases and implementation.
1m listen -
CMS Cyber Integration Center Leverages PenTesting to Protect Patient Data
Testing efforts help better identify vulnerabilities, coordinate incident response and mitigate risks.
15m listen
